Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4441.00 | 4286.50 | 1.0360 | 1.0454 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4739.00 | 4286.50 | 1.1056 | 1.1313 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1363.00 | 4286.50 | 0.3180 | -0.0321 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4360.00 | 4286.50 | 1.0171 | 1.0217 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4314.00 | 4286.50 | 1.0064 | 1.0081 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1250.00 | 4286.50 | 0.2916 | -0.0837 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4447.00 | 4286.50 | 1.0374 | 1.0471 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4505.00 | 4286.50 | 1.0510 | 1.0640 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2666.00 | 4286.50 | 0.6220 | 0.4805 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4600.00 | 4286.50 | 1.0731 | 1.0914 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 4334.00 | 4286.50 | 1.0111 | 1.0140 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1386.00 | 4286.50 | 0.3233 | -0.0217 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4191.00 | 4286.50 | 0.9777 | 0.9717 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7812.00 | 7946.50 | 0.9831 | 0.9774 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7823.00 | 7946.50 | 0.9845 | 0.9792 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 8025.00 | 7946.50 | 1.0099 | 1.0131 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7596.00 | 7946.50 | 0.9559 | 0.9408 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 6863.00 | 7946.50 | 0.8637 | 0.8139 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 4037.00 | 7946.50 | 0.5080 | 0.2735 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7950.00 | 7946.50 | 1.0004 | 1.0006 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 7937.00 | 7946.50 | 0.9988 | 0.9984 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 8145.00 | 7946.50 | 1.0250 | 1.0332 |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7511.00 | 7946.50 | 0.9452 | 0.9263 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 6769.00 | 7946.50 | 0.8518 | 0.7973 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6398.00 | 7946.50 | 0.8051 | 0.7310 |